A Heparanase-Inhibitory, bFGF-Binding Sulfated Oligosaccharide that Inhibits Angiogenesis Ex Ovo has Potent Antitumor and Antimetastatic Activity in Vivo

This publication has 13 references indexed in Scilit:

• Transcriptional and posttranscriptional regulation of urokinase‐type plasminogen activator expression in endothelial cells by basic fibroblast growth factor
  Journal of Cellular Physiology, 1995
• Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
  Nature Medicine, 1995
• Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation
  Cell, 1994
• Glycosaminoglycan-protein interactions: a question of specificity
  Current Opinion in Structural Biology, 1994
• Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesis
  Journal of Cellular Biochemistry, 1991
• Influence of Organ Environment on Extracellular Matrix Degradative Activity and Metastasis of Human Colon Carcinoma Cells
  JNCI: Journal of the National Cancer Institute, 1990
• In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice
  Clinical & Experimental Metastasis, 1989
• Angiogenic Factors
  Science, 1987
• Chemically modified heparins as inhibitors of heparan sulfate specific endo-.beta.-glucuronidase (heparanase) of metastatic melanoma cells
  Biochemistry, 1986
• Heparin potentiation of 3T3‐adipocyte stimulated angiogenesis: Mechanisms of action on endothelial cells
  Journal of Cellular Physiology, 1986